Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)
Condition(s):Ovarian Cancer, Primary Peritoneal CancerLast Updated:January 18, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Ovarian Cancer, Primary Peritoneal CancerLast Updated:January 18, 2013Completed
Condition(s):Classic Hodgkin LymphomaLast Updated:January 31, 2024Completed
Condition(s):Multiple MyelomaLast Updated:January 20, 2014Completed
Condition(s):Metastatic Breast CancerLast Updated:February 27, 2013Terminated
Condition(s):Breast CancerLast Updated:September 2, 2016Completed
Condition(s):Advanced Ovarian CancerLast Updated:January 27, 2023Completed
Condition(s):HER-2 Positive Breast CancerLast Updated:April 21, 2020Completed
Condition(s):Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal CancerLast Updated:September 26, 2019Completed
Condition(s):Ovarian CancerLast Updated:September 6, 2023Completed
Condition(s):Ovarian CancerLast Updated:September 30, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.